Studied in trials
Studied regimens (not recommendations)
Studied in trials — not a recommended dose
- The 2002 retinitis-pigmentosa report used 5 µg per eye by the parabulbar route for 10 days. This is historical study exposure, not a recommendation.
Dose evidence detail — Epitalon
Detailed dose evidence documented for Epitalon in its monograph — reference only, not dosing recommendations.
Reference only — not a dosing recommendation.
Not established
No approved labeled regimen
No established or recommended human dose.
- None identified in the United States or European Union. No current Russian primary regulator label was independently retrieved for this review.
Not established
What is not established
- No established or recommended human dose. Country-specific registration or historical study exposure does not establish a general regimen.
Epitalon — secção de evidência de dose e administração da monografia